NCT06680037 2026-02-27A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune DisordersTG Therapeutics, Inc.Phase 1 Recruiting32 enrolled
NCT06299748 2026-02-17A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.argenxRecruiting279 enrolled